These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 29732728)
1. Dyspepsia in non-steroidal anti-inflammatory drug users and the effect of preventive measures. Lee HL; Chua SS; Mahadeva S J Dig Dis; 2018 Jun; 19(6):342-349. PubMed ID: 29732728 [TBL] [Abstract][Full Text] [Related]
2. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study. Ho CW; Tse YK; Wu B; Mulder CJ; Chan FK Aliment Pharmacol Ther; 2013 Apr; 37(8):819-24. PubMed ID: 23432193 [TBL] [Abstract][Full Text] [Related]
3. Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients. Lanas A; Polo-Tomás M; Roncales P; Gonzalez MA; Zapardiel J Am J Gastroenterol; 2012 May; 107(5):707-14. PubMed ID: 22334248 [TBL] [Abstract][Full Text] [Related]
5. The rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an H2-receptor antagonist in Nova Scotia seniors starting nonsteroidal anti-inflammatory drug therapy. Superceanu B; Veldhuyzen van Zanten S; Skedgel C; Shepherd M; Sketris I Can J Gastroenterol; 2010 Aug; 24(8):481-8. PubMed ID: 20711527 [TBL] [Abstract][Full Text] [Related]
6. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110 [TBL] [Abstract][Full Text] [Related]
7. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications. Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097 [TBL] [Abstract][Full Text] [Related]
8. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database. Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933 [TBL] [Abstract][Full Text] [Related]
9. Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components. de Groot NL; Spiegel BM; van Haalen HG; de Wit NJ; Siersema PD; van Oijen MG Value Health; 2013; 16(5):769-77. PubMed ID: 23947970 [TBL] [Abstract][Full Text] [Related]
10. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591 [TBL] [Abstract][Full Text] [Related]
11. Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptions. Pasina L; Nobili A; Tettamanti M; Riva E; Lucca U; Piccinelli R; Defendi L; Perego L; Lucifora S; Bulla C Int J Clin Pharmacol Ther; 2010 Nov; 48(11):735-43. PubMed ID: 20979932 [TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs. Tseng CC; Wolfe MM Med Clin North Am; 2000 Sep; 84(5):1329-44. PubMed ID: 11026931 [TBL] [Abstract][Full Text] [Related]
13. NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care. Hollenz M; Stolte M; Leodolter A; Labenz J Dig Dis; 2006; 24(1-2):189-94. PubMed ID: 16699277 [TBL] [Abstract][Full Text] [Related]
14. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related]
15. Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis. Spiegel BM; Farid M; Dulai GS; Gralnek IM; Kanwal F Am J Med; 2006 May; 119(5):448.e27-36. PubMed ID: 16651060 [TBL] [Abstract][Full Text] [Related]
16. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan. Ishikawa S; Inaba T; Mizuno M; Okada H; Kuwaki K; Kuzume T; Yokota H; Fukuda Y; Takeda K; Nagano H; Wato M; Kawai K Acta Med Okayama; 2008 Feb; 62(1):29-36. PubMed ID: 18323869 [TBL] [Abstract][Full Text] [Related]
17. Mitigating GI risks associated with the use of NSAIDs. Momeni M; Katz JD Pain Med; 2013 Dec; 14 Suppl 1():S18-22. PubMed ID: 24373106 [TBL] [Abstract][Full Text] [Related]
18. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111 [TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of gastroprotective agent (GPA) use in adults with arthritis in the United States. Coyne KS; Margolis MK; Cappelleri JC; Hsieh R; Essex MN; Park PW; Joshi AV Curr Med Res Opin; 2013 May; 29(5):421-33. PubMed ID: 23444970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]